Related by context. Frequent words. (Click for all words.) 62 Co BMY 61 Initiates Phase II 61 gets USFDA nod 60 Presents Positive 60 Co MRK 59 Novartis Sanofi Aventis 58 Takeda Kyowa Hakko Kirin 57 Drug Shows Promise 57 Vytorin combines 57 Analysts Upgrades Downgrades 57 VP Exercises Options 57 PROFILE CO 57 www.gsk.com 57 Receives Orphan Drug Designation 56 http:/www.lilly.com 56 Movers Roundup 56 Wyeth 55 Corp. Nasdaq GENZ 55 FDA Accepts 55 GlaxoSmithKline Bristol Myers 55 Genentech GlaxoSmithKline 54 Premarket Roundup 54 children vaccine Prevnar 54 CFO Exercises Options 54 Completes Enrollment 54 Approaching Resistance 54 Develop Novel 54 Bifeprunox 54 Corp BSX 54 Japanese drugmaker Daiichi 54 http:/www.gsk.com 54 CEO Exercises Options 54 blood thinner Lovenox 54 3Q Profit Rises 53 leading lipid nanoparticle 53 Director Exercises Options 53 Wyeth Ayerst 53 3Q Profit Drops 53 Welcomes Analyst Initiation 53 Idec Roche 53 Inc Therapeutic Competitors 53 Meets Primary Endpoint 52 antidepressant Effexor 52 3Q Profit Jumps 52 Earnings Postmortem 52 GlaxoSmithKline AstraZeneca 52 Nasdaq AMGN 52 Earnings Scorecard 52 spokesman Tony Plohoros 52 Zacks Earnings Preview 52 Fablyn 52 4Q Profit Jumps 52 Prevnar vaccine 52 Enrolls First 52 NYSE PFE 51 Posts Smaller 51 commercialize phytocannabinoid based 51 Bayer HealthCare subsidiary 51 1Q Profit Rises 51 FY# Q3 earnings 51 GlaxoSmithKline plc NYSE 51 Vicuron Pharmaceuticals 51 By MOISEKAPENDA BOWER 51 3Q Profit Climbs 51 Ixempra 51 4Q Profit Up 51 Drug Candidate 51 NYSE SGP 51 Tibotec Pharmaceuticals Ltd. 51 NASDAQ SHPGY 50 2Q Profit Rises 50 Inc. FY# Q3 50 Eyetech Pharmaceuticals 50 Order Cheap Viagra 50 Guides Inline 50 Announces Presentation 50 3Q Profit Falls 50 Novartis AG NOVN.VX 50 Wyeth WYE.N Quote Profile 50 & Co MRK.N 50 GlaxoSmithKline Plc GSK.L 50 OSI Pharma 50 antibiotic Zithromax 50 2Q Profit Up 50 1Q Profit Falls 50 Roche ROG.VX 50 Profit Dips 50 Posts Narrower Loss 50 nyse PFE news 50 AstraZeneca Bristol Myers 50 HMG CoA reductase inhibitors 50 Glaxo Smithkline 49 R sorafenib tablets 49 Drugmaker Merck 49 Posts 1Q 49 Actelion Ltd. 49 1Q Profits 49 4Q Profit Falls 49 3Q Profit Up 49 Signs License Agreement 49 GlaxoSmithKline